Explore the Wonder

  • BioBytes: The Biotech Drug Delivery Timeline
    With Dr. David Targan — Biotech research holds a great deal of promise for future innovation in the treatment of previously untreatable diseases.  But how long does it take for a biotech therapy to come to market?  The answer may surprise you.  Due to the rigorous review process all drugs must undergo in the United States to ensure safety, it isn't uncommon for a 10-15 year time period to go by before a... Read more

Spotlight On

  • Federal Funding for Embryonic Stem Cell Research?
    From ereese — From the Washington Post:   Following last week’s court ruling cutting-off federal funding for embryonic stem cell research, biotech companies are moving ahead with privately-funded landmark human trials for innovative stem cell therapies.Learn more about Geron’s stem cell therapy for spinal cord injuries. Read more

Perspective

  • Misguided Fear of Biotech Should Not Translate to Regulatory Hurdles
    From Jim Greenwood — A recent editorial in the New York Times lays bare how demonization of biotechnology hinders innovations that can “save lives and protect the environment.” Opponents of genetic engineering stoke consumer distrust of biotechnology, against all evidence of the industry’s safety record, only to drive up regulatory costs for biotech companies, argue the authors, Pamela C. Read more

“Climate change is a global challenge that demands a global solution.”
— U.S. Agriculture Secretary Tom Vilsack

“Foundations generally will come out and allow you to throw the Hail Mary pass, the Doug Flutie with Boston College or the 50-yard bomb. Without that, we’re nowhere.”
— Rudy Tanzi, lead researcher for the Alzheimer’s Genome Project at Massachusetts General Hospital

“Never turn down a dollar. I’ve heard very few people say, ‘Gee, we raised too much money.’”
— Jim Imbler, president and CEO of ZeaChem

“These projects will help establish a domestic industry that will create jobs here at home and open new markets across rural America.”
— U.S. Energy Secretary Steven Chu

“Millions of people are waiting — some for a new treatment or a hoped-for cure, others for tools to enable economically and nutritionally sustainable food production, and nearly everyone for a more livable environment.”
— Jim Greenwood, BIO President and CEO

“Burdensome regulations on small businesses hurt our economy.”
— Rep. John Adler, D-N.J.

“It is an exciting time in agriculture as we work to meet the challenge of both feeding and fueling the world.”
— Bill Belden, member of the Council for Sustainable Biomass Production

“Our top priority is reducing backlog and addressing pendency concerns, and hopefully maintaining and increasing quality at the USPTO.”
— David Kappos, Director of the U.S. Patent and Trademark Office

“Whether we’re talking about equity investment or traditional bank loans, access to capital has always been a major obstacle for small firms.”
— Rep. Nydia M. Velázquez, D-N.Y.

“Best Management Practices are a much more useful way to ensure that agricultural producers communicate more with their peers, rather than onerous and business-inhibiting regulation.”
— Brian O'Connor, Manager of State Government Relations for BIO

Events View

  • Registration
  • Calendars
  • Video
View all...